Clinical Controversies in Aerosol Therapy for Infants and Children

Robert M DiBlasi1

  • 1Department of Pediatrics, Seattle Children's Hospital, and the Center for Developmental Therapeutics, Seattle Children's Hospital Research Institute, Seattle, Washington. robert.diblasi@seattlechildrens.org.

Respiratory Care
|June 14, 2015
PubMed

Insights

Optimizing aerosol drug delivery for pediatric patients requires specialized nebulizer technology and interfaces due to unique airway anatomy and breathing patterns in children. This review explores advancements and clinical debates in pediatric respiratory care.

Area of Science:

  • Pediatric Respiratory Care
  • Aerosol Drug Delivery Science
  • Medical Device Technology

Background:

  • Pediatric patients present unique challenges for aerosol therapy, including distinct airway anatomy, breathing patterns, and difficulty adhering to treatments.
  • Effective aerosol drug delivery is crucial for pediatric respiratory care but remains technically demanding for clinicians.

Purpose of the Study:

  • To review current research on pediatric nebulizer and interface devices for safe and efficient aerosol drug delivery.
  • To discuss clinical controversies and debates in pediatric aerosol science, informing best practices.

Main Methods:

  • Literature review focusing on pediatric nebulizer technology, interface devices, and aerosol delivery methods.
  • Analysis of clinical controversies including crying vs. resting infants, inhaler types, continuous nebulization, and ventilation strategies.

Main Results:

  • Advancements in nebulizer technology offer improved aerosol delivery options for pediatric patients.
  • Key areas of debate include optimal drug delivery methods and device performance during various ventilation modes.

Conclusions:

  • Tailored nebulizer and interface devices are essential for optimizing aerosol therapy in children.
  • Addressing clinical controversies and leveraging technological advancements can enhance the safety and efficacy of pediatric respiratory treatments.

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
388
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
859
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K